It was once a degree to some of the highest-paying jobs in the world, but now the University of California is seeing a drop in enrollment for computer science. Part of the reason is that tech ...

Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January. By Jan. 23 — less than three weeks after it became available — ...

Google is following last year’s Material 3 Expressive redesign on phones by introducing significantly more blur across Android 17. Based on images of internal builds that we and others have seen, ...

If you use multiple medications and think you don’t need a pill organizer or pill dispenser, think again. “Pill organizers are often considered an ‘elderly’ item, but they can be very helpful for ...

Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at ...

Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...